Cell Separation Market Is Anticipated To Witness Significant Growth Prospects With Rising CAGR By 20

Author : Mrudula Karmarkar | Published On : 22 Jan 2024

San Francisco, 22 January 2024: The Report Cell Separation Market Size, Share & Trends Analysis Report By Technique (Surface Marker, Filtration), By Cell Type (Human, Animal), By Application (Cancer Research, Stem Cell Research), By Product, By End-use, And Segment Forecasts, 2024 - 2030

The global cell separation market size is expected to reach USD 17.43 billion by 2030, registering a CAGR of 9.94% over the forecast period, according to a new report by Grand View Research, Inc. The increasing demand for biopharmaceuticals, such as recombinant therapeutic proteins, is anticipated to boost market growth. The key players focus on the development & commercialization of advanced products to cater to the needs of researchers and healthcare professionals, which is projected to drive the demand for cell isolation products in the near future.The usage of cellular therapies is increasing for the treatment of prominent diseases, including neurological diseases, such as amyotrophic lateral sclerosis, Parkinson’s disease, spinal cord injury, and renal, skeletal, & autoimmune diseases, such as multiple sclerosis, type 1 diabetes, & Crohn's disease.

In recent years, there has been an increase in funding from government organizations for cell-based research owing to its ability to treat & manage conditions, such as cancer and other chronic diseases. The global market witnessed an upward momentum during the pandemic. For instance, in 2020, Seattle Children's Research Institute's researchers used immunoprecipitation, identified by flow cytometry (IP-FCM) test, to study the immune response of COVID-19-infected patients. As per the experiment, blood samples were collected from 24 COVID-19-positive patients to compare with blood samples of 30 healthy individuals, and the compared samples were run through the IP-FCM test.Furthermore, increasing investments and government funding have helped boost the availability of technologically advanced processes for cell isolation & biopharmaceutical production. These advancements have resulted in an increased demand for cell separation procedures, thus propelling the market growth.

Cell separation plays an important role in various applications including biologics designing and development, therapeutic protein production, in-vitro diagnostics, and other research applications. Rising prevalence of chronic and infectious diseases, such as cancer and COVID-19, along with continuous government initiatives to improve the biotechnology industry are major factors boosting market growth. Product innovation is one of the key growth determinants of the market.

Various companies, such as NanoString Technologies, Levitas Bio, and Bionano Genomics, have undertaken product development strategies and expanded their offering. For instance, in April 2022, Levitas Bio announced the launch of LeviCell EOS System, their next-generation platform for cell separation. The new product enables a targeted selection of viable cells and has a relatively higher throughput than the company's existing products. In addition, the COVID-19 pandemic has provided researchers with an opportunity to investigate and comprehend this novel infectious virus and to discover therapies and diagnostic aids for it.

Request sample report of Cell Separation Market@ https://www.grandviewresearch.com/industry-analysis/cell-isolation-cell-separation-market/request/rs1

For instance, in March 2020, the U.S. President signed an emergency spending bill, wherein, USD 3 billion is accounted to be used for the R&D of vaccines, medical treatments, and test kits. This has significantly boosted the demand for cell separation tools in research applications.Cell separation or isolation techniques are widely used to develop and manufacture biologics, such as monoclonal antibodies and recombinant proteins. These products have been gaining traction over the past few decades. With the substantial growth of specialty drugs and personalized medicine, the demand for biologics has been increasing.

Cell Separation Market Report Highlights

  • The consumables product type segment held a major revenue share of 61.94% in 2023. The increasing investments in R&D by biopharmaceutical and biotech companies are a major factor propelling the segment growth
  • The biomolecule isolation application segment held the largest share of 29.5% in 2023 since it is a pivotal step in research on cancer, HIV, and other autoimmune diseases
  • The human cell type segment is anticipated to have a significant growth rate of 12.47% during the forecast period. The fast growth is due to the rising focus on human and cancer stem cell research and varied applications of isolated human cells
  • The centrifugation technique type segment held the highest market share of 42.3% in 2023. The availability of various centrifuges provides technicians with a wide range of options catering to their specific needs
  • North America dominated the global market with a revenue share of 39.8% in 2023 owing to increasing demand for new technologies, a large pool of key players, increasing development of vaccines and therapeutics, along with advanced healthcare infrastructure

According to CAS (A division of the American Chemical Society), it was estimated that biologics will grow to USD 399.5 billion by 2030. Moreover, the funding and current high demand have also motivated startups to enter the cell separation industry, despite the high cost of R&D. StartUs Insights identified and analyzed 957 startups in the field of cell and molecular biology solutions that are contributing to the sector growth. For instance, in October 2023, Veeda Group, in partnership with Atal Incubation Centre - Centre for Cellular and Molecular Biology (AIC - CCMB), newly introduced a half-day symposium in Hyderabad.

The event, titled “Integrated Phase I Trial Solutions for Emerging Biopharmaceuticals: Addressing Development Challenges and Accelerating Timelines,” focused on optimizing processes and overcoming challenges in the development of New Chemical Entities (NCEs) and Large Molecules. Furthermore, the growing prevalence of chronic diseases has increased the demand for diagnostics solutions and research applications. As per the American Cancer Society, in 2023, in the U.S. alone, more than 1.9 million new cases of cancer are projected to be diagnosed. According to the World Health Organization (WHO), 58 million people worldwide are suffering from chronic hepatitis C infectionwith approximately 1.5 million new infections occurring every year.

Cell Separation Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 9.87 billion

Revenue forecast in 2030

USD 17.43 billion

Growth rate

CAGR of 9.94% from 2024 to 2030

Base year for estimation

2023

Historical data

2018 - 2022

Forecast period

2024 - 2030

Instruments and related products can render accurate and effective results and have indispensable applications in the fields of disease diagnosis and scientific research. However, these products have high prices, which could, to some extent, restrict market growth. The techniques also involve a wide range of expenses for equipment, reagents, kits, sera, and services. The experimental setup and the reagents utilized for certain applications are pricey. These factors are anticipated to limit the industry growth to a certain extent during the forecast period.

Key players are engaged in organic and inorganic growth strategies, such as product-line expansion, collaborations, partnerships, mergers, and acquisitions, to garner high market share. For instance, in May 2023, Akadeum Life Sciences launched a new series of products, namely leukopak human immune cell isolation and T-cell activation/expansion kits for cell therapy R&D. Through this development, the company strengthens the company’s Leukopak cell isolation product lines.

List of Key Players in Cell Separation Market

  • Thermo Fisher Scientific, Inc.
  • BD
  • Danaher
  • Terumo Corp.
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Corning Inc.
  • Akadeum Life Sciences